Inventor · disambiguated record
Daniel J. Byrd
Also filed as: BYRD DANIEL J
7 granted patents·7 pending applications·0 citations·filing 2018–2024
74Inventor score
Files withKALIVIR IMMUNOTHERAPEUTICS INC9UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION2UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION2KaliVir Immunotherapeutics LLC1
Top patents by PatentIndex Score
14 records- 0184US12246049B2Oncolytic viruses targeting STAT3UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 0279US2025041368A1Oncolytic Immunotherapy by Tumor Micro-Environment RemodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0379US2025009824A1Oncolytic Immunotherapy by Tumor Micro-Environment RemodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0478US12403165B2Oncolytic immunotherapy by tumor micro-environment remodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2023·Granted Sep 2, 2025·0 cites·27 claims
- 0575US12472217B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Granted Nov 18, 2025·0 cites·22 claims
- 0674US12318419B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Jun 3, 2025·0 cites·15 claims
- 0774US12226440B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 0873US2022133824A1Oncolytic viruses targeting stat3UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 0972US2022133825A1Oncolytic viruses targeting stat3UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 1069US11253559B2Oncolytic viruses targeting STAT3UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2019·Granted Feb 22, 2022·0 cites·20 claims
- 1168US12036257B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2018·Granted Jul 16, 2024·0 cites·29 claims
- 1265US2021196770A1Platform oncolytic vector for systemic deliveryKaliVir Immunotherapeutics LLC·Filed 2021·Application pending·0 cites
- 1356US2022220505A1Producer Viruses for Generation of Retroviruses In SituKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1453US2022049228A1Modified Extracellular Enveloped VirusKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →